Detalles de la búsqueda
1.
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.
Lancet
; 403(10432): 1164-1175, 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402887
Resultados
1 -
1
de 1
1
Próxima >
>>